First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects
Clinical trial NCT02647281 · COMPLETED
Trial details
- NCT number
- NCT02647281
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2017-01-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.